MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

BIOADAPTIVES, INC. (BDPT)

BIOADAPTIVES, INC. (BDPT)

|||

Balance Sheets Overview

Current Ratio
5.43%
Quick Ratio
3.54%
Debt to Asset Ratio
1671.28%
Unit: Dollar
Assets Breakdown
    • Cash
    • Property and equipment, net
    • Prepaid expense
    • Security deposit
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Derivative liabilities
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Other receivable
NaN 0 2,800 2,800
Cash
73,606 158,445 59,273 210,582
Accounts receivable
NaN NaN 59 59
Inventory
42,968 44,706 44,228 39,574
Security deposit
2,500 2,500 2,500 2,500
Prepaid expense
4,375 6,250 0 0
Total current assets
123,449 211,901 108,860 255,515
License and patent, net
NaN 14,000 NaN NaN
Property and equipment, net
12,500 NaN 15,500 17,000
Total assets
135,949 225,901 124,360 272,515
Accounts payable and accrued liabilities
248,886 232,725 230,768 204,081
Derivative liabilities
1,563,920 1,738,804 967,406 860,636
Convertible notes
424,211 352,332 359,300 311,000
Notes payable
32,096 32,096 32,096 32,096
Stock payable
NaN NaN 0 0
Due to related party
2,978 NaN NaN NaN
Total current liabilities
2,272,091 2,355,957 1,589,570 1,407,813
Total liabilities
2,272,091 2,355,957 1,589,570 1,407,813
Series a preferred stock 4,000,000 shares designated 11,167 issued and outstanding as of march 31, 2026 and december 31, 2025-Series APreferred Stock
1 1 1 1
Series a preferred stock 4,000,000 shares designated 11,167 issued and outstanding as of march 31, 2026 and december 31, 2025-Series BPreferred Stock
1 1 1 1
Series a preferred stock 4,000,000 shares designated 11,167 issued and outstanding as of march 31, 2026 and december 31, 2025-Series CPreferred Stock
100 100 100 100
Series a preferred stock 4,000,000 shares designated 11,167 issued and outstanding as of march 31, 2026 and december 31, 2025-Series DPreferred Stock
27 20 16 13
Common stock (.0001 par value, 1,250,000,000 shares authorized 12,008,725 shares issued and outstanding as of march 31, 2026 and december 31, 2025, and 66 issuable)
1,200 1,200 1,093 994
Additional paid-in capital
8,700,704 8,595,711 8,437,322 8,387,834
Subscription receivable
5,885 5,885 5,885 5,885
Accumulated deficit
-10,832,290 -10,721,204 -9,897,858 -9,518,356
Total stockholders' deficit
-2,136,142 -2,130,056 -1,465,210 -1,135,298
Total liabilities and stockholders' deficit
135,949 225,901 124,360 272,515
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash$73,606 Inventory$42,968 Prepaid expense$4,375 Security deposit$2,500 Total current assets$123,449 Property and equipment,net$12,500 Total assets$135,949 Accumulated deficit-$10,832,290 Subscription receivable$5,885 Total liabilities andstockholders' deficit$135,949 Total stockholders'deficit-$2,136,142 Additional paid-in capital$8,700,704 Common stock (.0001 parvalue, 1,250,000,000...$1,200 Series a preferredstock 4,000,000...$100 Series a preferredstock 4,000,000...$27 Series a preferredstock 4,000,000...$1 Series a preferredstock 4,000,000...$1 Total liabilities$2,272,091 Total currentliabilities$2,272,091 Derivative liabilities$1,563,920 Convertible notes$424,211 Accounts payable andaccrued liabilities$248,886 Notes payable$32,096 Due to related party$2,978